Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It’s also up for accelerated approval by the U.S. Food and Drug Administration, with a decision expected by Jan. 6. However, the drug has also been linked to two deaths from brain bleeds among people who’ve… read on > read on >
Losing weight is one of the most popular New Year’s resolutions — possibly to give yourself an excuse for some New Year’s Eve overindulgence. “I’m going to cram it all in tonight, so tomorrow I start afresh,” jokes registered dietitian Connie Diekman, a nationally known food and nutrition consultant. But those waking up bleary-eyed on… read on > read on >
Could hydration hold the key to longevity? Maybe, suggests new research that discovered older adults who are properly hydrated may be healthier and live longer than those who aren’t, having less incidence of conditions like heart and lung disease. “Staying well-hydrated may slow down aging, prevent or delay development of chronic diseases, and therefore prolong… read on > read on >
If you’ve ever thought you must absorb more calories from food than other people do, you might be onto something: A new study hints that some people’s gut bacteria extract more energy, as in calories, from food — possibly contributing to weight gain. The study, of 85 overweight adults, found that those with a particular… read on > read on >
Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact. The U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq) for use in patients with advanced alveolar soft part sarcoma (ASPS) that has spread to other parts of… read on > read on >
Keeping allergies and asthma in check in the new year is a resolution worth keeping. With 2023 dawning, the American College of Allergy, Asthma and Immunology offers some suggestions for keeping symptoms under control all year long. “More than 50 million people in the U.S. suffer from allergic conditions,” said allergist Dr. Kathleen May, president… read on > read on >
COVID-19 patients could soon have a new antiviral pill they can take to guard against severe disease. The treatment, called VV116, worked as well as Paxlovid in people who were at high risk of severe disease in a phase 3 trial in China. The trial was a “great success,” study co-author Ren Zhao, a professor… read on > read on >
On Thursday, ZLINE Kitchen and Bath recalled certain models of its gas kitchen ranges because the oven can emit dangerous levels of carbon monoxide while in use, potentially causing serious injury or death. The company said it has received 44 reports of carbon monoxide emission from customers, including three reports of people needing medical attention.… read on > read on >
New Year’s resolutions can be a fickle thing. They are a time-honored way to promise improvements to yourself and your behavior, a “fresh start” to the new year. But if chosen poorly, a resolution also can be a source of anxiety, disappointment and hopelessness. “They tap into the abiding American spirit of relentless self-improvement, and… read on > read on >
FRIDAY, Dec. 30, 2022 (HealthDay News) – The United States could see a huge rise in diabetes among young people over the next several decades, a new modeling study finds. As many as 220,000 young people under the age of 20 could have type 2 diabetes in 2060, which would represent a nearly eight-fold increase,… read on > read on >
